AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 140 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $18,000 | -14.3% | 1,222 | -47.1% | 0.00% | -50.0% |
| Q1 2022 | $21,000 | -91.1% | 2,308 | -93.2% | 0.00% | -89.5% |
| Q4 2021 | $237,000 | +301.7% | 33,800 | +909.6% | 0.02% | +216.7% |
| Q1 2021 | $59,000 | +28.3% | 3,348 | +39.2% | 0.01% | +20.0% |
| Q3 2019 | $46,000 | -88.9% | 2,406 | -82.9% | 0.01% | -88.1% |
| Q2 2019 | $416,000 | +1160.6% | 14,085 | +1912.1% | 0.04% | +1300.0% |
| Q1 2019 | $33,000 | – | 700 | +4566.7% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 15 | -99.5% | 0.00% | -100.0% |
| Q3 2017 | $144,000 | +747.1% | 2,981 | +792.5% | 0.01% | +600.0% |
| Q2 2017 | $17,000 | -84.1% | 334 | -86.0% | 0.00% | -81.8% |
| Q1 2017 | $107,000 | +78.3% | 2,380 | +47.3% | 0.01% | +57.1% |
| Q3 2016 | $60,000 | -47.8% | 1,616 | -83.0% | 0.01% | -61.1% |
| Q1 2016 | $115,000 | -8.7% | 9,530 | +34.0% | 0.02% | -18.2% |
| Q3 2015 | $126,000 | +129.1% | 7,110 | +126.8% | 0.02% | +120.0% |
| Q2 2015 | $55,000 | 0.0% | 3,135 | +75.9% | 0.01% | -28.6% |
| Q1 2015 | $55,000 | – | 1,782 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|